4//SEC Filing
O'Day Daniel Patrick 4
Accession 0001638643-25-000013
CIK 0000882095other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:50 PM ET
Size
6.8 KB
Accession
0001638643-25-000013
Insider Transaction Report
Form 4
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
- Sale
Common Stock
2025-11-28$125.91/sh−3,212$404,428→ 577,991 total - Sale
Common Stock
2025-11-28$126.84/sh−6,788$861,016→ 571,203 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
- [F2]Sale prices for the transactions reported range from $125.41 to $126.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- [F3]Sale prices for the transactions reported range from $126.50 to $127.48. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001638643
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:50 PM ET
- Size
- 6.8 KB